Xenetic Biosciences, Inc
Price
FilingsNewest: 8-K, Regulation FD disclosureSep 23 →InsidersNo open-market buys or sales.→HoldersRenaissance Technologies 5.0%Geode 0.7%Vanguard 0.5%→Financing →PeersClosest companies: RNAZ, CNSP, TRAW→
From the filings
Figures
- Revenue
- $3.3Mlast 12 months
- Net income
- −$2.5Mlast 12 months
- Operating cash flow
- −$1.8Mlast 12 months
- Cash and equivalents
- $6.5Mat the last balance sheet
- Shares outstanding
- 2.3M shareson issue